Curiox Biosystems Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	11,324	24,188	17,909	5,597	11,003	7,043
Short-Term Investments	14,000	4,000	-	3,125	8,816	809.54
Cash & Short-Term Investments	25,324	28,188	17,909	8,722	19,819	7,853
Cash Growth	64.82%	57.39%	105.34%	-55.99%	152.38%	-
Accounts Receivable	585.2	557.32	1,723	1,832	1,240	1,146
Other Receivables	163.7	132.13	98.19	68.97	86.29	86.63
Receivables	748.9	689.45	1,821	1,901	1,326	1,232
Inventory	2,063	1,791	1,621	2,911	1,759	595.7
Prepaid Expenses	305.16	356.57	173.81	79.92	23.37	12.77
Other Current Assets	1,308	1,242	75.54	336.57	132.05	197.54
Total Current Assets	29,748	32,267	21,601	13,949	23,060	9,891
Property, Plant & Equipment	1,853	2,095	2,391	998.06	543.1	427.33
Long-Term Investments	-	-	-	-	0	-0
Goodwill	26,330	26,059	23,547	22,733	21,143	19,819
Other Intangible Assets	9,721	9,922	10,056	10,761	10,969	11,196
Other Long-Term Assets	223.08	217.71	203.37	185.77	78.5	32.68
Total Assets	67,875	70,561	57,798	48,627	55,793	41,367
Accounts Payable	88.43	190.32	330	929.48	937.19	127.39
Accrued Expenses	373.28	595.99	375.03	537.34	441.11	201
Short-Term Debt	7,806	7,398	-	-	30,148	11,857
Current Portion of Leases	403.51	423.79	358.97	219.12	56.96	25.65
Current Unearned Revenue	552.37	585.74	669.72	539.41	286.02	107.22
Other Current Liabilities	11,152	10,723	982.85	609.44	411.63	353.16
Total Current Liabilities	20,376	19,918	2,717	2,835	32,281	12,672
Long-Term Debt	-	-	-	-	-	126.73
Long-Term Leases	234.57	319.98	606.19	168.09	241.58	157.86
Long-Term Deferred Tax Liabilities	1,651	1,685	1,592	1,764	1,564	1,734
Other Long-Term Liabilities	-	0	-	0	0	-0
Total Liabilities	22,262	21,923	4,915	4,767	34,087	14,690
Common Stock	8,074	8,062	4,011	3,284	543	543
Additional Paid-In Capital	85,561	85,431	88,965	71,651	27,944	27,944
Retained Earnings	-57,173	-53,556	-45,466	-35,426	-23,931	-9,407
Comprehensive Income & Other	9,146	8,695	5,369	4,344	1,027	-1,805
Total Common Equity	45,609	48,632	52,879	43,853	5,582	17,274
Minority Interest	4.93	5.06	4.93	7.82	10.82	10.13
Shareholders' Equity	45,614	48,637	52,883	43,861	21,707	26,677
Total Liabilities & Equity	67,875	70,561	57,798	48,627	55,793	41,367
Total Debt	8,444	8,142	965.16	387.21	30,446	12,168
Net Cash (Debt)	16,880	20,045	16,944	8,334	-10,627	-4,315
Net Cash Growth	16.65%	18.30%	103.30%	-	-	-
Net Cash Per Share	1049.00	1216.70	1185.37	1174.42	-1630.92	-662.17
Filing Date Shares Outstanding	16.15	16.12	16.04	13.14	6.52	6.52
Total Common Shares Outstanding	16.15	16.12	16.04	13.14	6.52	6.52
Working Capital	9,373	12,349	18,884	11,115	-9,221	-2,781
Book Value Per Share	2824.25	3016.12	3295.64	3337.89	856.64	2651.04
Tangible Book Value	9,558	12,651	19,276	10,359	-26,530	-13,741
Tangible Book Value Per Share	591.88	784.63	1201.37	788.46	-4071.57	-2108.88
Machinery	2,671	2,837	2,440	1,219	740.14	704.78
Construction In Progress	102.45	102.38	-	-	-	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.